• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD226 通过磷酸化介导的转录因子 FOXO1 失活来调节自然杀伤细胞的抗肿瘤反应。

CD226 regulates natural killer cell antitumor responses via phosphorylation-mediated inactivation of transcription factor FOXO1.

机构信息

Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080.

Department of Bioinformatics and Computational Biology, Genentech, Inc., South San Francisco, CA 94080.

出版信息

Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):E11731-E11740. doi: 10.1073/pnas.1814052115. Epub 2018 Nov 30.

DOI:10.1073/pnas.1814052115
PMID:30504141
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6294892/
Abstract

Natural killer (NK) cell recognition of tumor cells is mediated through activating receptors such as CD226, with suppression of effector functions often controlled by negative regulatory transcription factors such as FOXO1. Here we show that CD226 regulation of NK cell cytotoxicity is facilitated through inactivation of FOXO1. Gene-expression analysis of NK cells isolated from syngeneic tumors grown in wild-type or CD226-deficient mice revealed dysregulated expression of FOXO1-regulated genes in the absence of CD226. In vitro cytotoxicity and stimulation assays demonstrated that CD226 is required for optimal killing of tumor target cells, with engagement of its ligand CD155 resulting in phosphorylation of FOXO1. CD226 deficiency or anti-CD226 antibody blockade impaired cytotoxicity with concomitant compromised inactivation of FOXO1. Furthermore, inhibitors of FOXO1 phosphorylation abrogated CD226-mediated signaling and effector responses. These results define a pathway by which CD226 exerts control of NK cell responses against tumors.

摘要

自然杀伤 (NK) 细胞通过激活受体(如 CD226)识别肿瘤细胞,其效应功能的抑制通常由 FOXO1 等负调控转录因子控制。在这里,我们表明 CD226 通过使 FOXO1 失活来调节 NK 细胞的细胞毒性。从在野生型或 CD226 缺陷型小鼠中生长的同源肿瘤中分离的 NK 细胞的基因表达分析显示,在缺乏 CD226 的情况下,FOXO1 调节的基因表达失调。体外细胞毒性和刺激实验表明,CD226 是杀伤肿瘤靶细胞的最佳杀伤所必需的,其配体 CD155 的结合导致 FOXO1 的磷酸化。CD226 缺陷或抗 CD226 抗体阻断会损害细胞毒性,同时使 FOXO1 失活受损。此外,FOXO1 磷酸化抑制剂阻断了 CD226 介导的信号转导和效应反应。这些结果定义了 CD226 对 NK 细胞针对肿瘤的反应进行控制的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a6/6294892/f9b08330968b/pnas.1814052115fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a6/6294892/61f91bc81062/pnas.1814052115fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a6/6294892/2186682e21ea/pnas.1814052115fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a6/6294892/a4012ae26645/pnas.1814052115fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a6/6294892/7081dc1cc308/pnas.1814052115fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a6/6294892/f9b08330968b/pnas.1814052115fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a6/6294892/61f91bc81062/pnas.1814052115fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a6/6294892/2186682e21ea/pnas.1814052115fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a6/6294892/a4012ae26645/pnas.1814052115fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a6/6294892/7081dc1cc308/pnas.1814052115fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a6/6294892/f9b08330968b/pnas.1814052115fig05.jpg

相似文献

1
CD226 regulates natural killer cell antitumor responses via phosphorylation-mediated inactivation of transcription factor FOXO1.CD226 通过磷酸化介导的转录因子 FOXO1 失活来调节自然杀伤细胞的抗肿瘤反应。
Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):E11731-E11740. doi: 10.1073/pnas.1814052115. Epub 2018 Nov 30.
2
Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).DNAX辅助分子-1(CD226)与其配体脊髓灰质炎病毒受体(CD155)和nectin-2(PRR-2/CD112)相互作用的功能特性
Int Immunol. 2004 Apr;16(4):533-8. doi: 10.1093/intimm/dxh059.
3
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions.CD96 和 CD226 受体在自然杀伤细胞功能的调节中相互拮抗。
Nat Immunol. 2014 May;15(5):431-8. doi: 10.1038/ni.2850. Epub 2014 Mar 23.
4
IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma.IL15 刺激联合 TIGIT 阻断逆转黑色素瘤中 CD155 介导的 NK 细胞功能障碍。
Clin Cancer Res. 2020 Oct 15;26(20):5520-5533. doi: 10.1158/1078-0432.CCR-20-0575. Epub 2020 Jun 26.
5
Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.通过 DNAM-1 和 NKG2D 增强自然杀伤细胞介导的肉瘤靶向作用。
Front Immunol. 2020 Jan 28;11:40. doi: 10.3389/fimmu.2020.00040. eCollection 2020.
6
Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cells.黏附受体CD226在小鼠自然杀伤细胞和T细胞上的异质性表达及其在自然杀伤细胞介导的未成熟树突状细胞杀伤中的作用。
J Leukoc Biol. 2009 Jul;86(1):91-101. doi: 10.1189/jlb.1208745. Epub 2009 Apr 20.
7
Contribution of inhibitory receptor TIGIT to NK cell education.抑制性受体 TIGIT 对 NK 细胞发育的贡献。
J Autoimmun. 2017 Jul;81:1-12. doi: 10.1016/j.jaut.2017.04.001. Epub 2017 Apr 21.
8
Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function.转录因子Foxo1是自然杀伤细胞成熟和功能的负调节因子。
Immunity. 2015 Mar 17;42(3):457-70. doi: 10.1016/j.immuni.2015.02.006. Epub 2015 Mar 10.
9
Increased Soluble CD226 in Sera of Patients with Cutaneous T-Cell Lymphoma Mediates Cytotoxic Activity against Tumor Cells via CD155.皮肤T细胞淋巴瘤患者血清中可溶性CD226增加,通过CD155介导对肿瘤细胞的细胞毒活性。
J Invest Dermatol. 2017 Aug;137(8):1766-1773. doi: 10.1016/j.jid.2017.03.025. Epub 2017 Apr 7.
10
Suppression of Natural Killer cell NKG2D and CD226 anti-tumour cascades by platelet cloaked cancer cells: Implications for the metastatic cascade.血小板伪装癌细胞对自然杀伤细胞 NKG2D 和 CD226 抗肿瘤级联反应的抑制作用:对转移级联的影响。
PLoS One. 2019 Mar 25;14(3):e0211538. doi: 10.1371/journal.pone.0211538. eCollection 2019.

引用本文的文献

1
Unlocking new frontiers: novel immune targets for next-generation cancer immunotherapy.开拓新领域:下一代癌症免疫疗法的新型免疫靶点
Korean J Clin Oncol. 2025 Aug;21(2):47-80. doi: 10.14216/kjco.24322. Epub 2025 Aug 31.
2
The Immune Regulatory Functions of CD226 and Its Implications in Immune-Mediated Diseases.CD226的免疫调节功能及其在免疫介导疾病中的意义。
Biomolecules. 2025 Jul 14;15(7):1007. doi: 10.3390/biom15071007.
3
Structure-guided engineering of CD112 receptor variants for optimized immunotherapy.用于优化免疫治疗的CD112受体变体的结构导向工程设计。

本文引用的文献

1
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity.阻断检查点受体 TIGIT 可防止 NK 细胞耗竭并引发强大的抗肿瘤免疫。
Nat Immunol. 2018 Jul;19(7):723-732. doi: 10.1038/s41590-018-0132-0. Epub 2018 Jun 18.
2
CRISPR off-target analysis in genetically engineered rats and mice.基因工程大鼠和小鼠中的 CRISPR 脱靶分析。
Nat Methods. 2018 Jul;15(7):512-514. doi: 10.1038/s41592-018-0011-5. Epub 2018 May 21.
3
CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity.
Mol Ther. 2025 Apr 24. doi: 10.1016/j.ymthe.2025.04.032.
4
Agent-based modeling of cellular dynamics in adoptive cell therapy.过继性细胞治疗中基于主体的细胞动力学建模
bioRxiv. 2025 Feb 21:2025.02.17.638701. doi: 10.1101/2025.02.17.638701.
5
Turning Cancer Immunotherapy to the Emerging Immune Checkpoint TIGIT: Will This Break Through the Limitations of the Legacy Approach?将癌症免疫疗法转向新兴免疫检查点TIGIT:这会突破传统方法的局限吗?
Vaccines (Basel). 2024 Nov 22;12(12):1306. doi: 10.3390/vaccines12121306.
6
Inhibition of CD226 co-stimulation suppresses diabetes development in the NOD mouse by augmenting regulatory T cells and diminishing effector T cell function.抑制CD226共刺激可通过增加调节性T细胞和减弱效应T细胞功能来抑制NOD小鼠的糖尿病发展。
Diabetologia. 2025 Feb;68(2):397-418. doi: 10.1007/s00125-024-06329-8. Epub 2024 Dec 5.
7
Spatial and Single-Cell Analyses Reveal Heterogeneity of DNAM-1 Receptor-Ligand Interactions That Instructs Intratumoral γδT-cell Activity.空间和单细胞分析揭示了指导肿瘤内γδT细胞活性的DNAM-1受体-配体相互作用的异质性。
Cancer Res. 2025 Jan 15;85(2):277-298. doi: 10.1158/0008-5472.CAN-24-1509.
8
Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization.自然杀伤细胞功能、信号转导、分子机制及临床应用的综合概述。
Signal Transduct Target Ther. 2024 Nov 8;9(1):302. doi: 10.1038/s41392-024-02005-w.
9
Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2.重新审视 T 细胞黏附分子作为癌症免疫治疗的潜在靶点:CD226 和 CD2。
Exp Mol Med. 2024 Oct;56(10):2113-2126. doi: 10.1038/s12276-024-01317-9. Epub 2024 Oct 1.
10
Inhibition of CD226 Co-Stimulation Suppresses Diabetes Development in the NOD Mouse by Augmenting Tregs and Diminishing Effector T Cell Function.抑制CD226共刺激通过增强调节性T细胞并削弱效应T细胞功能来抑制非肥胖糖尿病(NOD)小鼠的糖尿病发展。
bioRxiv. 2024 Jul 19:2024.07.16.603756. doi: 10.1101/2024.07.16.603756.
靶向CD96的抗体无需阻断CD96与CD155的相互作用即可促进自然杀伤细胞的抗转移活性。
Oncoimmunology. 2018 Feb 1;7(5):e1424677. doi: 10.1080/2162402X.2018.1424677. eCollection 2018.
4
Continuous activity of Foxo1 is required to prevent anergy and maintain the memory state of CD8 T cells.Foxo1 的持续活性对于预防无能(anergy)和维持 CD8 T 细胞的记忆状态是必需的。
J Exp Med. 2018 Feb 5;215(2):575-594. doi: 10.1084/jem.20170697. Epub 2017 Dec 27.
5
FOXO1 opposition of CD8 T cell effector programming confers early memory properties and phenotypic diversity.FOXO1 拮抗 CD8 T 细胞效应器编程赋予了早期记忆特性和表型多样性。
Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):E8865-E8874. doi: 10.1073/pnas.1618916114. Epub 2017 Oct 2.
6
natural killer cells fail to establish stable contacts with cancer cells and show impaired control of tumor metastasis .自然杀伤细胞无法与癌细胞建立稳定的接触,并且对肿瘤转移的控制能力受损。
Oncoimmunology. 2017 Jul 5;6(8):e1338994. doi: 10.1080/2162402X.2017.1338994. eCollection 2017.
7
TIGIT: A Key Inhibitor of the Cancer Immunity Cycle.TIGIT:癌症免疫循环的关键抑制剂。
Trends Immunol. 2017 Jan;38(1):20-28. doi: 10.1016/j.it.2016.10.002. Epub 2016 Oct 25.
8
Targeting natural killer cells in cancer immunotherapy.在癌症免疫疗法中靶向自然杀伤细胞。
Nat Immunol. 2016 Aug 19;17(9):1025-36. doi: 10.1038/ni.3518.
9
Transcription factor KLF2 regulates homeostatic NK cell proliferation and survival.转录因子KLF2调节稳态自然杀伤细胞的增殖和存活。
Proc Natl Acad Sci U S A. 2016 May 10;113(19):5370-5. doi: 10.1073/pnas.1521491113. Epub 2016 Apr 25.
10
Expression of DNAM-1 (CD226) on inflammatory monocytes.DNAM-1(CD226)在炎性单核细胞上的表达。
Mol Immunol. 2016 Jan;69:70-6. doi: 10.1016/j.molimm.2015.11.009. Epub 2015 Dec 8.